Shockwaves could ease stubborn knee pain without surgery
NCT ID NCT05596591
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if focused shockwave therapy can safely reduce knee pain and improve function in people with osteoarthritis who have bone marrow lesions. Fifteen adults with persistent knee pain will receive four weekly shockwave sessions or standard care (pain relievers and rest). Researchers will track pain, knee function, and MRI changes for six months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2022
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Males and females 30-80 years old, inclusive. 2. Kellgren-Lawrence (KL) score grade 2-4 as diagnosed on X-Ray. 3. Presence of BML(s) on MRI in a weight-bearing region of the knee (medial/lateral femoral condyle or tibial plateau). 4. Knee pain for more than 2 months. 5. Knee pain intensity during the week leading up to the screening visit is at least 4 out of 10 on an 11-point numerical rating scale (NRS; 0, no pain; 10, maximum pain imaginable). 6. Patient pain confined to the same compartment as the BML(s). 7. Subjects would have failed a minimum of 4 weeks of conservative treatment including rest, analgesics, limited weight-bearing with or without an assistive device. Exclusion Criteria: 1. Traumatic BMLs. 2. Primary cause of patient pain and loss of function is due to pathology other than BML(s), according to patient history and clinical evaluation. 3. Presence of bilateral BML(s). 4. Systemic autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. 5. Participants receiving glucocorticoids due to any other underlying disease. 6. Prior treatment for BMLs including: 1. Subchondroplasty in the involved knee. 2. Intraosseous and/or intra-articular injection of orthobiologics in the past 6 months, such as platelet rich plasma (PRP), bone marrow aspirate concentrates, micro-fragmented adipose tissue (MFAT) or stromal vascular fraction. 7. Prior use of bisphosphonates, except according to the washout schedule: 1. 2 years (if use \> 48 weeks). 2. 1 year (if used \> 8 weeks but \< 48 weeks) 3. 6 months (if used \> 2 weeks but \< 8 weeks) 4. 2 months (if used \< 2 weeks) 5. Any intravenous bisphosphonate within the prior 2 years. 8. Intra-articular steroid injection in the prior 3 months. 9. Previous knee surgery in the past 6 months. 10. Tumors 11. Infection or fracture on ipsilateral lower limb. 12. Pregnancy. 13. Contraindications to f-ESWT, such as severe coagulopathy, malignant tumor in the treatment area. 14. Contraindications to MRI scanning including: * Presence of metal implants such as implanted pacemaker, metal sutures, metallic protheses (including metal pins and rods, heart valves), presence of shrapnel or iron filings in the eye, magnetic dental implants, cochlear implants, cerebral aneurysm clip, and deep brain stimulator. * Claustrophobia. * The patient has been informed by his/her doctor that it is medically unsafe to receive regular MRI as part of his/her medical care.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone marrow edema are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Nathan Hogaboom
RECRUITINGWest Orange, New Jersey, 07052, United States
-
New Jersey Regenerative Institute
RECRUITINGCedar Knolls, New Jersey, 07927, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Can a shot of your own blood ease arthritic knees?
- 5,000 knee arthritis patients tracked to crack the treatment code
- Can a hydrogel injection ease knee arthritis pain?
- Weekly shot aims to melt away pounds in obesity fight
- Can shockwave plus injections quiet knee arthritis pain?